Asked by: Alexander Stafford (Conservative - Rother Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 23 January 2024 to Question 9963 on Vaccine Damage Payment Scheme: Coronavirus, how many and what proportion of those 163 claimants have received an award in relation to a COVID-19 vaccination specifically.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Of the 163 claims to the Vaccine Damage Payment Scheme that received an award between 31 December 2020 and 16 January 2024, 160 or 98% were claims related to COVID-19.
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 September to Question 197988 on Vaccine Damage Payment Scheme: Coronavirus, how many and what proportion of the 221 claims rejected due to not meeting the 60% disability threshold would have met a disability threshold of (a) 50%, b) 40%, c) 30% and (d) 20%.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Of the 221 COVID-19 related claims rejected due to not meeting the 60% disability threshold, as of 1 September 2023, only nine, or 4%, potentially would have met a disability threshold of 50%; 34, or 15%, potentially would have met a disability threshold of 40%; 73, or 33%, potentially would have met a disability threshold of 30%; and 116, or 53%, potentially would have met a disability threshold of 20%. The data for lower thresholds is cumulative and includes claims that would meet a higher threshold.
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 September 2023 to Question 197990 on Vaccine Damage Payment Scheme: Coronavirus, how many data subject access requests have been submitted for the 1,784 Vaccine Damage Payment Scheme claims which have been outstanding for over three months; and of those, how many data subject access requests have been outstanding for more than (a) six months, (b) three months and (c) one month.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
As of 1 September, of the 1,784 COVID-19 related claims that have been waiting for the provision of medical records for over three months, 314 claims have had subject access requests (SARs) submitted, with a total of 492 SARs between them. Claims usually have an average of two to three healthcare providers listed on their claim form, which results in multiple SARs being submitted for one claim. 1,470 claims have not had any SARs submitted. Due to previous SARs not receiving the desired outcome, steps are being taken to identify other avenues to engage with healthcare providers to gather medical records as quickly as possible and improve processing times.
Of the 492 SARs submitted, 62 (12%) have been outstanding more than six months, 276 (56%) have been outstanding more than three months, 280 (57%) have been outstanding more than one month, and two have been outstanding for less than a month. 210 (43%) of these SARs have resulted in the records being received.
Mentions:
1: Andrew Bridgen (Ind - North West Leicestershire) Yet again we are seeing a peak in covid hospitalisations, as we should be expecting from a coronavirus - Speech Link
2: Abena Oppong-Asare (Lab - Erith and Thamesmead) confirm again, that we believe vaccines are the most effective public health intervention in relation to coronavirus - Speech Link
3: Maria Caulfield (Con - Lewes) Although we have had over 8,000 claims to the vaccine damage payment scheme so far, 4,000 of them have - Speech Link
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 17 April 2023 to Question 176541 on Vaccine Damage Payment Scheme: Coronavirus, which safety concerns relating to covid-19 vaccines have been the subject of advice for (a) healthcare professionals and (b) patients since January 2021.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The United Kingdom Health Security Agency (UKHSA) publishes a range of resources to support healthcare professionals delivering the COVID-19 vaccination programme. Information on vaccine safety is available in the green book (chapter 14a), the primary professional source of guidance for front line immunisers, available at the following link:
https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14ai
Information on adverse events is available at the following links:
https://www.gov.uk/government/collections/covid-19-vaccination-and-rare-side-effects
UKHSA also produces patient information leaflets, which include information on rare side effects following vaccination. ‘What to expect after your COVID-19 vaccine’ is available at the following link:
https://www.gov.uk/government/publications/covid-19-vaccination-what-to-expect-after-vaccination
Vaccine safety remains at the forefront of the COVID-19 vaccine programme. The Medicines and Healthcare products Regulatory Agency is responsible for monitoring the safety of all COVID-19 vaccines approved in the United Kingdom.
Asked by: John Hayes (Conservative - South Holland and The Deepings)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many claims related to Covid-19 vaccinations have been made through the Vaccine Damage Payments Scheme.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
As of 26 April 2024, there have been 11,427 COVID-19 related claims made to the Vaccine Damage Payment Scheme.
Asked by: Alexander Stafford (Conservative - Rother Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what proportion of (a) compensation and (b) successful applications of awards given out by the vaccine damage payment scheme related to a covid-19 vaccinations since the addition of the covid-19 vaccines to the vaccine damage payment scheme.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Between COVID-19 being added to the Vaccine Damage Payment Scheme (VDPS) on 31 December 2020 and 5 February 2024, 163 claims have received an award that relates to COVID-19. This constitutes 98% of awarded VDPS claims in this period, with four claims receiving an award that relates to other diseases.
It is important to note that the VDPS is not a compensation scheme. £19,560,000 has been awarded for claims relating to COVID-19, including pending payments. This constitutes 98% of VDPS awards in this period, with £480,000 having been paid to awarded claims relating to other diseases.
Asked by: Alexander Stafford (Conservative - Rother Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many claimants to the Vaccine Damage Payment scheme (a) have been and (b) are due to be awarded money for a life-changing disability as a result of a covid-19 vaccine as of 5 February 2024.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
As of 5 February 2024, 163 claims to the Vaccine Damage Payment Scheme relating to COVID-19 have received an award. 154 of these claimants have received their payment, and in the remaining nine cases, the NHS Business Services Authority is awaiting relevant information from the claimant in order to process the payment. This gives a total of £18,480,000 paid out to successful COVID-19 related claims, with an additional £1,080,000 pending.
Asked by: Alexander Stafford (Conservative - Rother Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much money has been awarded by the vaccine damage payment scheme to claimants who suffered disabilities as a result of a COVID-19 vaccine.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
As of 5 February 2024, 163 claims to the Vaccine Damage Payment Scheme relating to COVID-19 have received an award. 154 of these claimants have received their payment, and in the remaining nine cases, the NHS Business Services Authority is awaiting relevant information from the claimant in order to process the payment. This gives a total of £18,480,000 paid out to successful COVID-19 related claims, with an additional £1,080,000 pending.
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many claims to the Vaccine Damage Payment Scheme relating to covid-19 vaccines where causation has been established and where (a) the 60% disablement threshold has been met, (b) that threshold has not been met, have arisen as a result of (i) Vaccine-induced thrombocytopenia and thrombosis, (ii) Guillain-Barré syndrome and (iii) any other condition.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
As of 31 January 2024, of the 163 COVID-19 related applications to the Vaccine Damage Payment Scheme that have received an award, 69 cases were related to cerebral venous sinus thrombosis, 49 were related to Guillain-Barré syndrome and 45 cases were related to other medical conditions.
Of the 300 cases where causation was accepted but the individual did not meet the 60% threshold, 50 cases were related to cerebral venous sinus thrombosis, 63 were related to Guillain-Barré syndrome and 187 cases were related to other medical conditions.